Research

Paediatric Cancer Treatment

Search Projects

Projects

  • Inmunoterapia del glioma difuso de protuberancia (DIPG)

    Leader
    Angel Montero Carcaboso
    Announcement
    FIS
    Code
    PI15/01161
    Starting date
    2016
    End date
    2019
    Funded by
    Instituto de Salud Carlos III (ISCIII)

  • Cure2DIPG_Nanocarriers modified with a protease-resistant BBB shuttle for targeted CNS drug delivery in diffuse intrinsic pontine glioma

    Leader
    Angel Montero Carcaboso
    Announcement
    Acciones complementarias
    Code
    AC15/00006
    Starting date
    2016
    End date
    2018
    Funded by
    Instituto de Salud Carlos III (ISCIII)

  • Retinoblastoma

    Leader
    Guillermo Chantada , Jaume Mora Graupera
    Code
    PFNR0063
    Starting date
    2015
    End date
    3000
    Funded by
    Clientes Diversos

  • Cure4RB

    Leader
    Angel Montero Carcaboso
    Announcement
    Retos colaboración 2015
    Code
    RTC-2015-4319-1
    Starting date
    2015
    End date
    2019
    Funded by
    Ministerio de Economía Y Competitividad (MINECO)

  • Miguel Servet - Translational research program in diffuse intrinsic pontine gliomas. Beneficiario: Angel Montero

    Leader
    Angel Montero Carcaboso
    Announcement
    Miguel Servet
    Code
    MS13/00189
    Starting date
    2014
    End date
    2019
    Funded by
    Instituto de Salud Carlos III (ISCIII)

  • Translational research program in diffuse intrinsic pontine gliomas

    Leader
    Angel Montero Carcaboso
    Announcement
    Miguel Servet
    Code
    CP13/00189
    Starting date
    2014
    End date
    2018
    Funded by
    Instituto de Salud Carlos III (ISCIII)

  • Beca de investigación HSJD -Translational research program in diffuse intrinsic pontine gliomas. Beneficiario: Sonia Paco Mercader

    Leader
    Angel Montero Carcaboso
    Announcement
    Beques Recerca HSJD
    Code
    BR201301
    Starting date
    2014
    End date
    2017
    Funded by
    Hospital Sant Joan de Déu - Esplugues HSJD

  • Distribución limitada de fármacos al microambiente tumoral como causa de Quimioresistencia en neuroblastoma.

    Leader
    Angel Montero Carcaboso
    Code
    PFNF0017
    Starting date
    2012
    End date
    2015
    Funded by
    Fundación Banco Bilbao Vizcaya Argentaria

  • Investigación en fármacos más activos contra tumores infantiles de mal pronóstico

    Leader
    Angel Montero Carcaboso
    Code
    20948
    Starting date
    2012
    End date
    2012
    Funded by
    Fundación Caja de Navarra

  • Marie Curie - Neuroblastoma Chemo. Chemotherapy of neuroblastoma. Beneficiary: Dr. Angel Montero

    Leader
    Angel Montero Carcaboso
    Code
    PIRG08-GA-2010-276998
    Starting date
    2011
    End date
    2015
    Funded by
    European Commission